Comorbidity between bipolar disorder and alcohol use disorder: Association of dopamine and serotonin gene polymorphisms

Psychiatry Research

Volumn 176, Issue 1, 2010, Pages 30-33

  Yasseen, Baseer ^a   Kennedy, James L ^b,c   Zawertailo, Laurie A ^a,c   Busto, Usoa E ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Alcoholism; Bipolar disorder; Comorbidity; Genetics

Indexed keywords

CYSTEINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; SERINE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ALCOHOLISM; AMINO ACID SUBSTITUTION; ARTICLE; BIPOLAR DISORDER; CHI SQUARE TEST; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC DATABASE; GENETIC POLYMORPHISM; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ADULT; ALCOHOL-RELATED DISORDERS; BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CYSTEINE; DATABASES, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEUROTRANSMITTER TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SERINE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 76549133752     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.12.009     Document Type: Article

References (46)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 4th ed. (1994), American Psychiatric Association, Washington
2. Carter T.D., Mundo E., Parikh S.V., and Kennedy J.L. Early age at onset as a risk factor for poor outcome of bipolar disorder. Journal of Psychiatric Research 37 4 (2003) 297-303
3. Comings D.E., Gade R., Wu S., Chiu C., Dietz G., Muhleman D., Saucier G., Ferry L., Rosenthal R.J., Lesieur H.R., Rugle L.J., and MacMurray P. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Molecular Psychiatry 2 1 (1997) 44-56
4. Curran G.M., Flynn H.A., Kirchner J., and Booth B.M. Depression after alcohol treatment as a risk factor for relapse among male veterans. Journal of Substance Abuse Treatment 19 3 (2000) 259-265
5. Dalton E.J., Cate-Carter T.D., Mundo E., Parikh S.V., and Kennedy J.L. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disorders 5 1 (2003) 58-61
6. Dmitrzak-Weglarz M., Rybakowski J.K., Slopien A., Czerski P.M., Leszczynska-Rodziewicz A., Kapelski P., Kaczmarkiewicz-Fass M., and Hauser J. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology 53 1 (2006) 46-50
7. Elvidge G., Jones I., McCandless F., Asherson P., Owen M.J., and Craddock N. Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: results of analysis and meta-analysis. American Journal of Medical Genetics 105 4 (2001) 307-311
8. Fehr C., Szegedi A., Anghelescu I., Klawe C., Hiemke C., and Dahmen N. Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatric Genetics 10 2 (2000) 59-65
9. Fortney J.C., Booth B.M., and Curran G.M. Do patients with alcohol dependence use more services? A comparative analysis with other chronic disorders. Alcoholism, Clinical and Experimental Research 23 1 (1999) 127-133
10. Fossey M.D., Otto M.W., Yates W.R., Wisniewski S.R., Gyulai L., Allen M.H., Miklowitz D.J., Coon K.A., Ostacher M.J., Neel J.L., Thase M.E., Sachs G.S., and Weiss R.D. Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. American Journal of Addiction 15 2 (2006) 138-143
11. Frye M.A., and Salloum I.M. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disorders 8 6 (2006) 677-685
12. Hayden E.P., and Nurnberger Jr. J.I. Molecular genetics of bipolar disorder. Genes, Brain, and Behavior 5 1 (2006) 85-95
13. Jacob T., Waterman B., Heath A., True W., Bucholz K.K., Haber R., Scherrer J., and Fu Q. Genetic and environmental effects on offspring alcoholism: new insights using an offspring-of-twins design. Archives of General Psychiatry 60 12 (2003) 1265-1272
14. Kasper S.F. Living with bipolar disorder. Expert Review of Neurotherapeutics 4 6 Suppl 2 (2004) S9-15
15. Keck Jr. P.E., McElroy S.L., Strakowski S.M., West S.A., Sax K.W., Hawkins J.M., Bourne M.L., and Haggard P. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. American Journal of Psychiatry 155 5 (1998) 646-652
16. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., and Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51 1 (1994) 8-19
17. Kogan J.N., Otto M.W., Bauer M.S., Dennehy E.B., Miklowitz D.J., Zhang H.W., Ketter T., Rudorfer M.V., Wisniewski S.R., Thase M.E., Calabrese J., and Sachs G.S. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disorders 6 6 (2004) 460-469
18. Kupfer D.J., Frank E., Grochocinski V.J., Cluss P.A., Houck P.R., and Stapf D.A. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. Journal of Clinical Psychiatry 63 2 (2002) 120-125
19. Lappalainen J., Long J.C., Virkkunen M., Ozaki N., Goldman D., and Linnoila M. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Biological Psychiatry 46 6 (1999) 821-826
20. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 5292 (1996) 1527-1531
21. Leszczynska-Rodziewicz A., Hauser J., Dmitrzak-Weglarz M., Skibinka M., Czerski P., Zakrzewska A., Kosmowska M., and Rybakowski J.K. Lack of association between polymorphisms of dopamine receptors, type D2, and bipolar affective illness in a Polish population. Medical Science Monitor 11 6 (2005) CR289-295
22. Lichtermann D., Hranilovic D., Trixler M., Franke P., Jernej B., Delmo C.D., Knapp M., Schwab S.G., Maier W., and Wildenauer D.B. Support for allelic association of a polymorphic site in the promoter region of the serotonin transporter gene with risk for alcohol dependence. American Journal of Psychiatry 157 12 (2000) 2045-2047
23. Limosin F., Romo L., Batel P., Ades J., Boni C., and Gorwood P. Association between dopamine receptor D3 gene BalI polymorphism and cognitive impulsiveness in alcohol-dependent men. European Psychiatry 20 3 (2005) 304-306
24. McElroy S.L., Altshuler L.L., Suppes T., Keck Jr. P.E., Frye M.A., Denicoff K.D., Nolen W.A., Kupka R.W., Leverich G.S., Rochussen J.R., Rush A.J., and Post R.M. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. American Journal of Psychiatry 158 3 (2001) 420-426
25. McGuffin P., and Katz R. The genetics of depression and manic-depressive disorder. British Journal of Psychiatry 155 (1989) 294-304
26. McQueen M.B., Devlin B., Faraone S.V., Nimgaonkar V.L., Sklar P., Smoller J.W., Abou Jamra R., Albus M., Bacanu S.A., Baron M., Barrett T.B., Berrettini W., Blacker D., Byerley W., Cichon S., Coryell W., Craddock N., Daly M.J., Depaulo J.R., Edenberg H.J., Foroud T., Gill M., Gilliam T.C., Hamshere M., Jones I., Jones L., Juo S.H., Kelsoe J.R., Lambert D., Lange C., Lerer B., Liu J., Maier W., Mackinnon J.D., McInnis M.G., McMahon F.J., Murphy D.L., Nothen M.M., Nurnberger J.I., Pato C.N., Pato M.T., Potash J.B., Propping P., Pulver A.E., Rice J.P., Rietschel M., Scheftner W., Schumacher J., Segurado R., Van Steen K., Xie W., Zandi P.P., and Laird N.M. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. American Journal of Medical Genetics 77 4 (2005) 582-595
27. Muller D.J., de Luca V., Sicard T., King N., Strauss J., and Kennedy J.L. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. British Journal of Psychiatry 189 (2006) 317-323
28. Munafo M.R., Lingford-Hughes A.R., Johnstone E.C., and Walton R.T. Association between the serotonin transporter gene and alcohol consumption in social drinkers. American Journal of Medical Genetics B. Neuropsychiatric Genetics 135B 1 (2005) 10-14
29. Mundo E., Zai G., Lee L., Parikh S.V., and Kennedy J.L. The 5HT1Dbeta receptor gene in bipolar disorder: a family-based association study. Neuropsychopharmacology 25 4 (2001) 608-613
30. Murphy G.E., Wetzel R.D., Robins E., and McEvoy L. Multiple risk factors predict suicide in alcoholism. Archives of General Psychiatry 49 6 (1992) 459-463
31. Noble E.P. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 16 1 (1998) 33-45
32. Noble E.P. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. European Psychiatry 15 2 (2000) 79-89
33. Nurnberger Jr. J.I., Foroud T., Flury L., Su J., Meyer E.T., Hu K., Crowe R., Edenberg H., Goate A., Bierut L., Reich T., Schuckit M., and Reich W. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. American Journal of Psychiatry 158 5 (2001) 718-724
34. Parsian A., and Cloninger C.R. Serotonergic pathway genes and subtypes of alcoholism: association studies. Psychiatric Genetics 11 2 (2001) 89-94
35. Parsian A., Chakraverty S., and Todd R.D. Possible association between the dopamine D3 receptor gene and bipolar affective disorder. American Journal of Medical Genetics 60 3 (1995) 234-237
36. Prescott C.A., Hewitt J.K., Truett K.R., Heath A.C., Neale M.C., and Eaves L.J. Genetic and environmental influences on lifetime alcohol-related problems in a volunteer sample of older twins. Journal of Studies on Alcohol 55 2 (1994) 184-202
37. Ranade S.S., Mansour H., Wood J., Chowdari K.V., Brar L.K., Kupfer D.J., and Nimgaonkar V.L. Linkage and association between serotonin 2A receptor gene polymorphisms and bipolar I disorder. American Journal of Medical Genetics B. Neuropsychiatric Genetics 121B 1 (2003) 28-34
38. Samochowiec J., Ladehoff M., Pelz J., Smolka M., Schmidt L.G., Rommelspacher H., and Finckh U. Predominant influence of the 3′-region of dopamine D2 receptor gene (DRD2) on the clinical phenotype in German alcoholics. Pharmacogenetics 10 5 (2000) 471-475
39. Sander T., Harms H., Podschus J., Finckh U., Nickel B., Rolfs A., Rommelspacher H., and Schmidt L.G. Dopamine D1, D2 and D3 receptor genes in alcohol dependence. Psychiatric Genetics 5 4 (1995) 171-176
40. Segurado R., Detera-Wadleigh S.D., Levinson D.F., Lewis C.M., Gill M., Nurnberger Jr. J.I., Craddock N., DePaulo J.R., Baron M., Gershon E.S., Ekholm J., Cichon S., Turecki G., Claes S., Kelsoe J.R., Schofield P.R., Badenhop R.F., Morissette J., Coon H., Blackwood D., McInnes L.A., Foroud T., Edenberg H.J., Reich T., Rice J.P., Goate A., McInnis M.G., McMahon F.J., Badner J.A., Goldin L.R., Bennett P., Willour V.L., Zandi P.P., Liu J., Gilliam C., Juo S.H., Berrettini W.H., Yoshikawa T., Peltonen L., Lonnqvist J., Nothen M.M., Schumacher J., Windemuth C., Rietschel M., Propping P., Maier W., Alda M., Grof P., Rouleau G.A., Del-Favero J., Van Broeckhoven C., Mendlewicz J., Adolfsson R., Spence M.A., Luebbert H., Adams L.J., Donald J.A., Mitchell P.B., Barden N., Shink E., Byerley W., Muir W., Visscher P.M., Macgregor S., Gurling H., Kalsi G., McQuillin A., Escamilla M.A., Reus V.I., Leon P., Freimer N.B., Ewald H., Kruse T.A., Mors O., Radhakrishna U., Blouin J.L., Antonarakis S.E., and Akarsu N. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. American Journal of Medical Genetics 73 1 (2003) 49-62
41. Severino G., Congiu D., Serreli C., De Lisa R., Chillotti C., Del Zompo M., and Piccardi M.P. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. American Journal of Medical Genetics B. Neuropsychiatric Genetics 134B 1 (2005) 37-38
42. Suppes T., Leverich G.S., Keck P.E., Nolen W.A., Denicoff K.D., Altshuler L.L., McElroy S.L., Rush A.J., Kupka R., Frye M.A., Bickel M., and Post R.M. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. Journal of Affective Disorders 67 1-3 (2001) 45-59
43. Szczepankiewicz A., Dmitrzak-Weglarz M., Skibinska M., Slopien A., Leszczynska-Rodziewicz A., Czerski P., and Hauser J. Study of dopamine receptors genes polymorphisms in bipolar patients with comorbid alcohol abuse. Alcohol and Alcoholism 42 2 (2007) 70-74
44. Thome J., Weijers H.G., Wiesbeck G.A., Sian J., Nara K., Boning J., and Riederer P. Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating. Psychiatric Genetics 9 1 (1999) 17-21
45. Tyndale R.F. Genetics of alcohol and tobacco use in humans. Annals of Medicine 35 2 (2003) 94-121
46. Wodarz N., Bobbe G., Eichhammer P., Weijers H.G., Wiesbeck G.A., and Johann M. The candidate gene approach in alcoholism: are there gender-specific differences?. Archives of Women's Mental Health 6 4 (2003) 225-230